Chiropractor News

Drug candidate stops extra bone growth in animal model of rare, genetic disease
PHILADELPHIA - New preclinical research provides support to a drug that has been repurposed to possibly treat a rare and extremely disabling genetic bone disease, particularly in children. In that disease, fibrodysplasia ossificans progressiva FOP , a mutation triggers bone growth in muscles, alters skeletal bone formation, and limits motion, breathing, and swallowing, among a host of progressive ...
EurekAlert - Wed. Apr 13
Would changing gait pattern decrease your likelihood of running injuries?
ROSEMONT, Ill. April 6, 2016 --Are runners less injury-prone trekking barefoot than in pricey running shoes Maybe, according to a new literature review in the March issue of the Journal of the American Academy of Orthopaedic Surgeons JAAOS . Advances in running shoe technology in the last 40 years have not reduced injuries, but racing barefoot in shoes with minimal cushioning could help runners ch ...
EurekAlert - Thu. Apr 7
Young arthritis patients have unique concerns about treatment
They describe a wide range of consequences--physical, emotional, social, and vocational--arising from their treatment. The findings indicate that young arthritis patients need active encouragement to discuss their treatment concerns and difficulties, so that a balance can be achieved between disease control and treatment burden. Young people can have severe arthritis, warranting aggressive treatme ...
EurekAlert - Thu. Apr 7
For young people with schizophrenia, physical and mental exercises offer hope
In as little as a few months, antipsychotic medications can tame the delusions and hallucinations that characterize schizophrenia. But the medications do little to reverse the less familiar brain-based problems that accompany the illness. Affecting memory, the speed at which the brain processes information, attention, problem-solving skills and emotional intelligence, these subtle but profound def ...
EurekAlert - Wed. Apr 6
Insights into new targets and promising treatments for musculoskeletal disease
Great progress has been made in the understanding of the genes and molecular pathways that contribute to the pathogenesis of bone and muscle diseases. As a result of these advances, several new molecular targets have been identified for drug design - knowledge which is being harnessed for the development of new treatment options for sarcopenia and metabolic bone diseases such as osteoporosis, hypo ...
EurekAlert - Wed. Apr 6
Most patients likely to see reductions in pain and disability after bariatric ...
PITTSBURGH, April 5, 2016 - In the three years following bariatric surgery, the majority of patients experienced an improvement in pain and walking ability, as well as a lessening of the degree to which back or leg pain interfered with work, according a University of Pittsburgh Graduate School of Public Health-led analysis of a multi-site clinical study published today in the Journal of the Americ ...
EurekAlert - Tue. Apr 5
Risk of breaking a bone depends on where you live
Ethnicity, socioeconomic status and place of residence in the UK all influence the risk of breaking a bone, a new Southampton study has shown. Researchers at the Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, undertook an analysis of the UK Clinical Practice Research Datalink database and calculated the risk of an individual experiencing a fracture. They also exa ...
EurekAlert - Tue. Apr 5
Aromatase inhibitors plus growth hormone may help short adolescent boys grow t...
Boston, MA-- Aromatase inhibitors, when used for up to three years in combination with growth hormone, may effectively and safely help very short adolescent boys grow taller, new research suggests. The study results will be presented Sunday, April 3, at ENDO 2016, the annual meeting of the Endocrine Society in Boston. Treating the growth-retarded child in puberty presents significant challenges no ...
EurekAlert - Mon. Apr 4
Bone density lower with use of ADHD stimulant medicine
Boston, MA-- Children and teenagers who take stimulant drugs to treat attention-deficit hyperactivity disorder ADHD may have lower bone density than their peers who do not take these medications, a new study finds. The study results will be presented Friday at the Endocrine Society s 98th annual meeting in Boston. Stimulants, such as methylphenidate Ritalin and other brands and amphetamine, are fr ...
EurekAlert - Mon. Apr 4
SSRI antidepressants promote bone loss during lactation
Boston, MA-- Antidepressant use with selective serotonin reuptake inhibitors SSRIs during pregnancy and breast-feeding causes decreased bone density in mothers that may put them at higher risk of broken bones later in life, a new study suggests. Researchers will present the results of their animal study Friday at the Endocrine Society s 98th annual meeting in Boston. SSRIs are the most widely pres ...
EurekAlert - Mon. Apr 4
Abaloparatide may help prevent fractures in postmenopausal women with osteopor...
Boston, MA-- The investigational drug abaloparatide-SC subcutaneous may help increase bone mineral density in postmenopausal women and reduce their risk of fracture, new industry-sponsored research suggests. The results of the subgroup analysis within the ACTIVE clinical trial will be presented Friday, April 1, at ENDO 2016, the annual meeting of the Endocrine Society in Boston. Abaloparatide-SC i ...
EurekAlert - Sun. Apr 3
More dietary calcium may lower risk of cardiovascular disease
Boston, MA - In older people, higher dietary calcium intake may lower the risk of cardiovascular disease, but not of stroke and fracture, new research from South Korea suggests. The results will be presented in a poster Saturday, April 2, at ENDO 2016, the annual meeting of the Endocrine Society, in Boston. The role of dietary calcium intake in cardiovascular disease, stroke and fracture is contro ...
EurekAlert - Sat. Apr 2